Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-14

Clinical Trial Results: Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a combination probiotic (BB-12 with LGG) at different doses for treating children with autism spectrum disorder and associat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BB-12 with LGG (probiotic combination)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Autism Spectrum Disorder, Gastrointestinal Symptoms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-08-14